Clinical Trial Update: Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing frontline alemtuzumab (Campath, MabCampath) to chlorambucil in progressive B-cell chronic lymphocytic leukemia has completed, evaluati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Alemtuzumab (Campath, MabCampath) (alemtuzumab)
• Chlorambucil (chlorambucil)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: B Cell Chronic Lymphocytic Leukemia | Phase 3 | Status: COMPLETED